All Industry articles – Page 14
-
BusinessRegulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
BusinessModerna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
OpinionThe ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
OpinionA promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
BusinessEarly indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
BusinessInnovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
NewsUS imposes sanctions on Russian institution linked to refinery cyber attack
Russia’s Chemistry and Mechanics research institute is accused of connections to Triton malware
-
BusinessStepping towards diversity in industry
Companies are re-affirming their commitment to inclusivity, even as the US government obstructs education efforts
-
OpinionImproving executive diversity is a priority
A few hiring decisions could make a big difference at leadership level
-
BusinessEU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
BusinessCovid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
OpinionThe Nobel prize that got binned
Ferrocene is a classic example of a discovery that was dismissed as a failed experiment
-
BusinessArkema acquitted over hurricane fire emissions
US Judge rules there is insufficient evidence to bring criminal charges relating to peroxide fire caused by flooding in 2017
-
OpinionBlood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
NewsEnvironmental groups propose tax on basic chemical manufacturing
A coordinated 0.5% fee on chemical feedstocks could generate $11.5bn to fund chemicals and waste management globally
-
OpinionJumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
BusinessCovid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
BusinessRosa Biotech gets biosensors on the nose
Protein barrel arrays mimic mammals’ olfactory system to distinguish many different molecules
-
BusinessRussian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V